Latest News

The 2025 Yale Faculty Innovation Awards honor academic founders whose startups—rooted in Yale research—are advancing breakthroughs in health, sustainability, and engineering.

Mosquito saliva is known to play a significant role in the transmission of viruses such as yellow fever, Zika, dengue, and chikungunya, yet many of its functions remain to be understood. In a new study, researchers revealed that a mosquito salivary protein binds to an immune molecule in humans, facilitating infection in the human skin caused by the transmitted virus.

Yale's Center for Infection & Immunity, directed by Akiko Iwasaki, PhD, will lead the funded research.

A Yale-led study found that unsaturated fats such as those found in olive oil can alleviate symptoms of colitis in mice.

A new study led by Yale Cancer Center researchers at Yale School of Medicine reveals that a specific population of CD8+ T-cells marked by IL-7R play an important role in better understanding anti-tumor memory.

A group of Yale researchers is working on a new kind of vaccine they believe could change the world: instead of acting against a pathogen, the vaccine would reduce the risk of transmission for mosquito-and-tick-borne illnesses by targeting the insects themselves.

The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of biomedical and digital health innovations.

Two Yale labs will lead projects, in collaboration with other leading universities, tasked with developing new approaches to understand and combat pathogens.

Despite the critical role of neutrophils in the human immune system, no one has been able to study them in a living context, limiting investigations of their properties. But now, a team of Yale researchers has developed the first humanized mouse model that will permit research on neutrophils in vivo.